United States v. Matthew Puccio
Opinion
NOT PRECEDENTIAL
UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT
No. 23-2260
UNITED STATES OF AMERICA
v.
MATTHEW PUCCIO,
Appellant
On Appeal from the United States District Court For the District of New Jersey (D.C. No. 2-21-cr-00157-001)
District Judge: Honorable John M. Vazquez
Submitted Under Third Circuit L.A.R. 34.1(a)
September 3, 2024
Before: JORDAN, HARDIMAN, and PORTER, Circuit Judges
(Filed: September 6, 2024)
OPINION
JORDAN, Circuit Judge.
Matthew Puccio appeals his conviction and sentence for conspiracy to commit healthcare fraud. He contends that the District Court erred in instructing the jury on
This disposition is not an opinion of the full court and, pursuant to I.O.P. 5.7, does not constitute binding precedent.
willful blindness, and that the Court should not have applied a managerial role enhancement pursuant to Sentencing Guideline § 3B1.1. Neither argument has merit. Accordingly, we will affirm. I. BACKGROUND A. The Scheme Puccio worked as a sales representative for Rep Network (“RN”), a marketing company for prescription compound medications,1 including topical pain and scar creams and vitamin supplements. Compound medications must be prescribed by a doctor. Because not all medical plans cover the cost of these expensive medications, RN and compounding pharmacies targeted individuals with health insurance plans that covered compounded medications. The New Jersey School Employees’ Health Benefits Program (the “SEHBP”), which provided medical and prescription drug coverage to qualified public school employees, was one such plan.
Puccio received a commission for every prescription he caused to be filled, as well as any filled prescriptions generated by sales representatives he recruited. To increase commissions, and because he knew their insurance plan would cover the medications, Puccio persuaded his brother-in-law, Peter Frazzano, and other New Jersey public school
educators to receive compounded medications.2 Eventually, Puccio recruited Frazzano to become a sales representative for RN, which also increased Puccio’s potential commissions. He taught Frazzano to increase commissions by, for example, focusing on the highest-yield medications and maximizing prescription refills.
Puccio and Frazzano discussed recruiting schoolteachers in Frazzano’s school as “patients” to receive medications because they knew SEHBP would cover the costs of the compounds. Puccio also instructed Frazzano to find a doctor who would sign teachers’ prescriptions, which led them to Dr. Gregg Marella. Puccio and Frazzano treated Dr. Marella to multiple dinners, bringing along pre-filled prescriptions for the schoolteachers for Dr. Marella to sign, even though Marella had never examined those patients. During one of those dinners, Puccio and Frazzano bribed Marella with $500 in cash to continue the fraudulent operation.
In other words, Puccio profited by causing false and fraudulent prescriptions for unnecessary compound medications to be filled, resulting in fraudulent claims to health insurers, including the SEHBP. Through the scheme, Puccio caused the SEHBP to lose more than $2.6 million it paid for medically unnecessary and fraudulent prescriptions, and Puccio made approximately $215,000 in commissions on those prescriptions.
In September 2017, the FBI questioned Frazzano about the scheme. Immediately following that conversation, Frazzano contacted Puccio, who went to Frazzano’s home.
Puccio spoke to the president of RN and then told Frazzano to call the teachers that they had recruited and tell them to lie to the FBI by saying that they saw a doctor and were prescribed the medications and that no one paid them to do so. Puccio also told Frazzano to delete all communications on his phone related to the scheme, but when Frazzano was too nervous to comply, Puccio took Frazzano’s phone and deleted that content himself.
B. The Defense Puccio was indicted and convicted of conspiracy to commit healthcare fraud, contrary to 18 U.S.C. § 1347, in violation of 18 U.S.C. § 1349. At trial, Puccio testified that he did not know about any fraudulent activity. He denied recruiting Frazzano as a sales representative, claiming instead to have only introduced him to another sales representative and not knowing what happened afterwards. Contrary to testimony from both Frazzano and Dr. Marella, Puccio also denied completing prescription forms with patients’ information before giving them to Dr. Marella to sign.
Based on Puccio’s defense that he was not aware of the scheme to commit healthcare fraud, the government requested that the jury be instructed on willful blindness. Over Puccio’s objection, the District Court granted the government’s request to include the instruction, and charged the jury using our model instruction. The jury returned a guilty verdict.
C. Sentencing Prior to sentencing, the government recommended a three-level enhancement under § 3B1.1(b) of the guidelines for Puccio’s role as a manager or supervisor (but not an organizer or leader) of criminal activity involving five or more participants. Puccio
objected to the enhancement, arguing that he was not the “architect” of the scheme and that no one worked for, or under, him. After hearing argument on the issue at sentencing, the District Court found that Puccio recruited Frazzano into the scheme; Puccio stated in emails that Frazzano worked under him; Puccio directed Frazzano to find other teachers to be patients and covered their co-pays; and Puccio managed Frazzano’s attempted cover up following the FBI interaction. Based on those facts, the Court found that Puccio supervised Frazzano but applied a two-level sentencing enhancement under U.S.S.G. § 3B1.1(c) rather than a three-level enhancement under subsection (b).
That enhancement resulted in a guidelines range of 78 to 97 months’
imprisonment. The government recommended a downward variance to between 60 and 72 months, and Puccio asked the Court to consider that variance while also asking for a greater downward variance. Ultimately, the Court granted the government’s requested variance and imposed a term of 60 months’ imprisonment, followed by three years of supervised release. Puccio timely appealed. II. DISCUSSION3 Puccio first argues that the District Court erred in providing a jury instruction on willful blindness, and that the charge as a whole was confusing and contradictory. He also
argues that the District Court clearly erred when it applied a managerial role enhancement pursuant to § 3B1.1(b) of the guidelines. He is mistaken on both issues.
A. The District Court did not err in providing the willful blindness instruction.
The District Court instructed the jury that Puccio’s conspiracy charge required the government to prove that: (1) two or more persons agreed to commit healthcare fraud, (2) Puccio was a party to or a member of that agreement, and (3) Puccio joined the agreement or conspiracy knowing of its objective to commit healthcare fraud, and intended to join together with at least one other conspirator to achieve that objective. Thus, the jury had to find that Puccio “had knowledge of the specific objective contemplated by the … conspiracy.” United States v. Caraballo-Rodriguez, 726 F.3d 418, 425 (3d Cir. 2013) (en banc). Because “willful blindness is a subset of knowledge[,]” and “an alternative way of proving knowledge[,]” “proof of willful blindness [can be] sufficient to prove knowledge[.]” United States v. One 1973 Rolls Royce, V.I.N. SRH-16266 ex rel. Goodman, 43 F.3d 794, 813 (3d Cir. 1994). “Thus, the government could satisfy the [charge’s] knowledge requirement by demonstrating actual knowledge or willful blindness, which is a subjective state of mind that is deemed to
satisfy a scienter requirement of knowledge.” Caraballo-Rodriguez, 726 F.3d at 420 n.2 (internal quotation marks omitted).
Free access — add to your briefcase to read the full text and ask questions with AI
United States v. Matthew Puccio (United States v. Matthew Puccio) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.